Inventor · disambiguated record
Jiasheng Fu
Also filed as: FU JIASHENG
10 granted patents·8 pending applications·36 citations·filing 2005–2023
86Inventor score
Files withAMGEN INC13CONNORS RICHARD V2PERENNA PHARMACEUTICALS INC2SHANGHAI QILU PHARMACEUTICAL RES AND DEVELOPMENT CENTRE LTD1
Top patents by PatentIndex Score
18 records- 0188US9593129B2Piperidinone derivatives as MDM2 inhibitors for the treatment of cancerAMGEN INC·Filed 2016·Granted Mar 14, 2017·5 cites·18 claims
- 0288US9296736B2Piperidinone derivatives as MDM2 inhibitors for the treatment of cancerAMGEN INC·Filed 2014·Granted Mar 29, 2016·7 cites·13 claims
- 0387US2024300892A1Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of CancerAMGEN INC·Filed 2023·Application pending·0 cites
- 0486US9376425B2Heterocyclic compounds as MDM2 inhibitors for the treatment of cancerAMGEN INC·Filed 2012·Granted Jun 28, 2016·12 cites·37 claims
- 0581US11306107B2Compounds that inhibit MCL-1 proteinAMGEN INC·Filed 2017·Granted Apr 19, 2022·2 cites·11 claims
- 0680US8841312B2Fused pyridine, pyrimidine and triazine compounds as cell cycle inhibitorsCONNORS RICHARD V·Filed 2008·Granted Sep 23, 2014·6 cites·35 claims
- 0780US2022169611A1Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of CancerAMGEN INC·Filed 2022·Application pending·0 cites
- 0875US8389533B2Gem-disubstituted and spirocyclic amino pyridines/pyrimidines as cell cycle inhibitorsCONNORS RICHARD V·Filed 2009·Granted Mar 5, 2013·3 cites·20 claims
- 0974US2021179560A1Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of CancerAMGEN INC·Filed 2020·Application pending·0 cites
- 1069US11208404B2Compounds useful as inhibitors of ALCAT 1PERENNA PHARMACEUTICALS INC·Filed 2018·Granted Dec 28, 2021·1 cites·6 claims
- 1167US2019062276A1Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of CancerAMGEN INC·Filed 2018·Application pending·0 cites
- 1265US2025368667A1Usp1 inhibitorSHANGHAI QILU PHARMACEUTICAL RES AND DEVELOPMENT CENTRE LTD·Filed 2023·Application pending·0 cites
- 1365US2014011796A1Piperidinone derivatives as mdm2 inhibitors for the treatment of cancerAMGEN INC·Filed 2013·Application pending·0 cites
- 1464US2017144971A1Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of CancerAMGEN INC·Filed 2017·Application pending·0 cites
- 1557US2022089582A1Compounds useful as inhibitors of alcat 1PERENNA PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1654US8980903B2Fused pyridine, pyrimidine and triazine compounds as cell cycle inhibitorsAMGEN INC·Filed 2014·Granted Mar 17, 2015·0 cites·22 claims
- 1743US7763624B2Substituted pyrazolo[3,4-d]pyrimidines as ACK-1 and LCK inhibitorsAMGEN INC·Filed 2006·Granted Jul 27, 2010·0 cites·34 claims
- 1842US7674907B2Furanopyridine derivatives and methods of useAMGEN INC·Filed 2005·Granted Mar 9, 2010·0 cites·13 claims
Join the waitlist — get patent alerts
Get an alert when Jiasheng Fu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →